Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Future prospects of brain stimulation.

A L Benabid1, A Koudsié, P Pollak

  • 1Inserm U 318, CHU of Grenoble, France.

Neurological Research
|April 19, 2000
PubMed
Summary

High frequency stimulation (HFS) of the subthalamic nucleus (STN) effectively treats Parkinson's disease symptoms, including tremor, rigidity, and akinesia. This advanced neuromodulation technique offers stable, long-term symptom control and may benefit other neurological disorders.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Managing spine surgery referrals: The consultation of neurosurgery and its nuances.

Neuro-Chirurgie·2017
Same author

Spatial distribution of marine debris on the seafloor of Moroccan waters.

Marine pollution bulletin·2017
Same author

Twenty-four years of deep brain stimulation of the subthalamic nucleus.

Revue neurologique·2017
Same author

Deep brain stimulation of the subthalamic nucleus in Parkinson's disease: From history to the interaction with the monoaminergic systems.

Progress in neurobiology·2016
Same author

The impact of combined administration of paraquat and maneb on motor and non-motor functions in the rat.

Neuroscience·2015
Same author

Intraoperative 3D imaging control during subthalamic Deep Brain Stimulation procedures using O-arm® technology: Experience in 15 patients.

Neuro-Chirurgie·2014

Area of Science:

  • Neuroscience
  • Neurosurgery
  • Neurology

Background:

  • Chronic high-frequency stimulation (HFS) of the thalamic ventral intermediate nucleus (Vim) has become a standard treatment for tremor.
  • HFS has been extended to other targets, including the subthalamic nucleus (STN) and the medial globus pallidus (GPi), since 1993.

Purpose of the Study:

  • To evaluate the efficacy and mechanisms of HFS in treating various neurological disorders, with a focus on STN stimulation for Parkinson's disease.
  • To explore the potential of STN stimulation for managing cardinal symptoms and levodopa-induced complications.

Main Methods:

  • Application of chronic high-frequency stimulation (130 Hz) to specific brain targets, primarily the STN.
  • Experimental data from rat and monkey models informed the extension of HFS to new targets.

Related Experiment Videos

Main Results:

  • STN stimulation effectively controls the three cardinal symptoms of Parkinson's disease: tremor, akinesia, and rigidity.
  • Levodopa treatment reduction or cessation is possible, subsequently suppressing levodopa-induced dyskinesias.
  • Effects of chronic STN HFS remain stable for over five years, establishing it as a preferred surgical option for Parkinson's disease, especially for bilateral procedures.

Conclusions:

  • STN HFS is a highly effective and stable treatment for Parkinson's disease, offering significant symptom alleviation and improved quality of life.
  • Emerging evidence suggests STN stimulation may also be beneficial for dystonia and certain epilepsies, highlighting its potential for broader neurological applications.
  • Future advancements in brain stimulation technologies, waveforms, and targets hold promise for treating a wider range of neurological disorders.